GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HitGen Inc (SHSE:688222) » Definitions » Institutional Ownership

HitGen (SHSE:688222) Institutional Ownership : 1.80% (As of Sep. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is HitGen Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, HitGen's institutional ownership is 1.80%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, HitGen's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, HitGen's Float Percentage Of Total Shares Outstanding is 0.00%.


HitGen Institutional Ownership Historical Data

The historical data trend for HitGen's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HitGen Institutional Ownership Chart

HitGen Historical Data

The historical data trend for HitGen can be seen below:

2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31
Institutional Ownership 1.03 2.23 2.23 2.23 2.23 2.23 2.29 1.80 1.80 1.80

HitGen Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


HitGen Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Section 2, Biocity Middle Road, Chengdu Tianfu International Biological City, Shuangliu District, Sichuan Province, Chengdu, CHN, 610093
HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.

HitGen Headlines

No Headlines